Translational and Commercial Research Advisory Committee

    Chair:

    Ms. Kathryn Smith
    Business consultant to for-profit and not-for-profit healthcare companies and foundations

    Members:

    Dr. Samuel David
    Basic Scientist, McGill University
    Area of expertise: cellular changes and molecular mechanisms that influence inflammation following nerve tissue damage

    Dr. Mark Moore
    Co-Founder and Chief Executive Officer, Glialogix
    Area of expertise: drug discovery and biotechnology start-ups

    Dr. John Richert
    Principal, Richert Partners
    Area of expertise: research and clinical programs in non-profit sector and pharmaceutical development

    Ms. Jenny Lee Gauthier
    MS Society volunteer and middle school teacher,
    Campbellton, NB
    Lay member